Improving Regulatory Transparency for New Medical Therapies Act

Improving Regulatory Transparency for New Medical Therapies Act.

Author/creator	United States
Format	Electronic and Book
Publication Info	[Washington, D.C.] : [U.S. Government Publishing Office], [2015]
Description	1 online resource (6 unnumbered pages)
Supplemental Content	PDF version
Supplemental Content	Text version
Subject(s)	Drugs of abuse--Law and legislation --United States. Drug approval--United States.

Caption title	Act to Amend the Controlled Substances Act with Respect to Drug Scheduling Recommendations by the Secretary of Health and Human Services, and with Respect to Registration of Manufacturers and Distributors Seeking to Conduct Clinical Testing
General note	Title from title screen (viewed on Feb. 11, 2016).
General note	"Nov. 25, 2015 (H.R. 639)"--Page [1].
General note	"129 Stat. 698"--Page [1].
General note	"Public Law 114-89."
Issued in other form	Print version: United States. Improving Regulatory Transparency for New Medical Therapies Act
Genre/form	Statutes and codes.
Technical rpt number	Public Law 114-89
GPO item number	0575-A-02 (online)
Govt. docs number	AE 2.110:114-89

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	View Online Content	✔ Available